查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1503308

到 2030 年弱视市场预测：按类型、诊断、治疗、应用和地区分類的全球分析

Lazy Eye Market Forecasts to 2030 - Global Analysis By Type, Diagnosis, Treatment, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球低视力市场规模为 32.6 亿美元，预计到 2030 年将达到 49.2 亿美元，预测期内复合年增长率为 7.1%。

当一个人戴着处方眼镜或隐形眼镜无法达到正常视力时，就会出现一种称为弱视的发展性视力障碍。它通常始于儿童时期，当时眼睛和大脑仍在发育。弱视是一种大脑偏爱一隻眼睛而不是另一隻眼睛的疾病，导致受影响眼睛的视力下降。其他常见原因包括眼睛屈光不正的显着差异、斜视（眼睛错位）以及其他影响眼睛的疾病，例如白内障。

根据美国眼科学会的数据，弱视（俗称忽视）是儿童视力丧失最常见的原因，在美国每 100 名儿童中约有 2 至 3 人受到影响。

弱视病例增加

由于多种因素，包括遗传倾向、出生率上升以及萤幕使用和户外活动减少等环境因素，弱视在世界各地变得越来越普遍。鑑于盛行率不断增加，有效的诊断和管理方法至关重要。如果不及时治疗，弱视可能会导致永久性视力障碍，因此早期发现至关重要。此外，随着医疗保健提供者努力解决这一常见问题，对治疗解决方案的需求不断增加，推动市场成长。

最先进治疗的价格过高

该市场成长的主要障碍之一是先进弱视治疗的高成本，例如数位治疗系统和专门的矫正镜片。最终用户必须为许多尖端解决方案支付高额成本，这是由于其研发、生产和行销相关的高成本。没有足够医疗保险的家庭或生活在低收入地区的人可能会感到这种经济负担尤其沉重。此外，由于这个原因，这些治疗方法的成本仍然是各个社会经济群体采用和利用这些治疗方法的主要障碍。

新兴市场的成长

弱视治疗市场在新兴经济体有着巨大的扩张潜力。拉丁美洲、亚洲和非洲国​​家都在经历经济成长，并正在发展医疗基础设施。随着对眼睛健康问题的了解和可支配收入的增加，对有效弱视治疗的需求也增加。此外，对于有意进入这些市场的公司来说，很大程度上开拓的消费群可能是一个优势。

患者依从性问题

成功的弱视治疗最重要的方面之一是患者的依从性。许多治疗方法，例如阿托品眼药水和眼贴，必须长期持续使用才能有效。然而，患者的依从性很难维持，特别是当患者年轻并且可能对某些治疗方法感到不舒服或受到耻辱时。此外，违规从可能导致治疗结果不理想、降低治疗效果并增加退出率。需要解决合规问题，以提高治疗效果和市场永续性。

COVID-19 的影响：

由于医疗保健服务中断以及常规眼科检查和治疗的延误，COVID-19 的爆发对弱视治疗市场产生了重大影响。锁上门和其他保持社交距离的策略减少了患者去看眼科医师的次数，往往会延迟弱视的早期发现和治疗。此外，由于疫情带来的经济负担和经济不安全感，一些家庭没有优先考虑非紧急医疗保健，包括低视力治疗。

斜视场预计在预测期间内最大

斜视弱视领域在斜视（弱视）市场占有率最大。由于眼睛错位（称为斜视），斜视性弱视是最常见的弱视类型。为了防止双眼视觉，大脑会优先考虑一隻眼睛而不是另一隻眼睛，从而导致未对准的眼睛的视觉发育不良。早期诊断和治疗对于调整眼睛和改善视力至关重要。此外，这些手术通常涉及使用眼罩、矫正眼镜或手术。

预计在预测期内，筛检领域的复合年增长率最高。

斜视（弱视）市场的照片筛检部分预计将以最高复合年增长率成长。照片筛检涉及使用专用的相机和软体为孩子的眼睛拍照。分析这些影像以查找弱视的危险因素，例如斜视和屈光不正。这种方法特别有益，因为它快速、非侵入性且易于使用，即使对于不配合传统眼科检查的幼儿也是如此。此外，由于多种因素，该市场正在迅速扩大，包括儿科筛检的普及、照片筛检技术的进步以及对早期检测价值的日益了解。

占比最大的地区：

北美，尤其是美国，由于先进的医疗保健系统、较高的认知度和易于获得的治疗方案而在弱视市场中占据主导地位。由于痴呆症在美国非常普遍，因此有一个健康的市场，得到强大的製药公司、受人尊敬的研究设施以及治疗视力丧失的积极方法的支持。此外，该国在北美盲眼市场的巨大市场占有率归因于其对医疗保健创新和治疗方式的广泛可用性的关注。

复合年增长率最高的地区：

中国、日本和印度等亚太地区的复合年增长率最高。医疗保健成本上升、公众对眼科疾病的认识不断提高以及获得医疗保健的便利性（尤其是在农村地区）等因素正在推动这一增长。此外，中国和印度等国家由于人口众多、弱视病例不断增加以及注重发展医疗基础设施，预计将显着增长。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球低视力市场：依类型

  • 斜视
  • 屈光弱视
  • 形觉剥夺性弱视
  • 屈光参差性弱视
  • 闭塞性弱视
  • 其他类型

第六章全球弱视市场：依诊断

  • 斜视测试
  • 一般眼科检查
  • 视力检查
  • 照片筛检
  • 布鲁克纳测试

第七章全球弱视市场：依治疗分类

  • 矫正眼镜
    • 隐形眼镜
    • 眼镜
  • 外科手术
  • 眼罩
  • 阿托品眼药水
  • 电玩游戏
  • 其他治疗方法

第八章全球低视力市场：依应用分类

  • 医院
  • 专科诊所
  • 零售药房
  • 眼科诊所
  • 其他应用

第九章全球低视力市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Johnson And Johnson Services, Inc
  • Golden Vision
  • Krafty Eye Patches
  • Adwia Pharmaceuticals
  • NovaSight
  • 3M
  • Pfizer Inc
  • TCI Chemicals Pvt. Ltd
  • Rebion
  • Bausch & Lomb Incorporated
  • Opthopatch
  • Vivid Vision, Inc
  • Hilco Vision
  • Walgreens
  • Fresnel Prism & Lens
Product Code: SMRC26474

According to Stratistics MRC, the Global Lazy Eye Market is accounted for $3.26 billion in 2024 and is expected to reach $4.92 billion by 2030 growing at a CAGR of 7.1% during the forecast period. A vision development disorder known as lazy eye, or amblyopia, occurs when one eye is unable to achieve normal visual acuity, even with prescription eyeglasses or contact lenses. It usually begins in childhood, when the eyes and brain are still growing. Amblyopia is a condition in which the brain prefers one eye over the other, impairing vision in the affected eye. Moreover, common causes include significant differences in the prescription (refractive error) between the two eyes, strabismus (misalignment of the eyes), or other conditions affecting the eyes, such as cataracts.

According to the American Academy of Ophthalmology, amblyopia, commonly known as lazy eye, is the most common cause of visual impairment in children, affecting approximately 2 to 3 out of every 100 children in the United States.

Market Dynamics:

Driver:

Growing number of amblyopia cases

Due to a number of factors, including genetic predispositions, rising birth rates, and environmental factors like screen time and fewer outdoor activities, amblyopia is becoming more commonplace worldwide. An efficient diagnosis and management approach is imperative in light of this increasing prevalence. It is imperative to detect amblyopia early on because, if left untreated, it can cause permanent visual impairments. Moreover, as healthcare providers strive to address this prevalent condition, the demand for treatment solutions is growing, driving market growth.

Restraint:

Exorbitant price of cutting-edge therapies

One major obstacle to the growth of this market is the high cost of advanced amblyopia treatments, such as digital therapy systems and specialty corrective lenses. The high costs that end users must pay for many of these cutting-edge solutions stem from the significant costs associated with their R&D, production, and marketing. Families without sufficient health insurance or those residing in low-income areas may find this financial burden especially difficult. Additionally, because of this, the cost of these treatments continues to be a major barrier to their adoption and accessibility by a variety of socioeconomic groups.

Opportunity:

Growth in emerging markets

There is a big chance for the market for amblyopia treatments to expand in emerging economies. Latin American, Asian, and African nations are all seeing increases in their economies, as well as improvements to their infrastructure for healthcare. The demand for efficient amblyopia treatments is raising as knowledge of eye health issues and disposable incomes both rise. Furthermore, a largely unexplored consumer base can be advantageous to businesses that deliberately enter these markets.

Threat:

Problems with Patient Compliance

One of the most important aspects of amblyopia treatment success is patient compliance. For many treatment modalities, like atropine drops and eye patches, to be effective, they must be used consistently over an extended period of time. But it can be difficult to keep patients compliant, particularly when they are young and may find certain treatments upsetting or stigmatizing. Moreover, non-compliance may result in less than ideal treatment results, which may lower the treatments' perceived efficacy and possibly increase the dropout rate. Improving the effectiveness of treatment and the sustainability of the market require addressing compliance issues.

Covid-19 Impact:

Due to disruptions in healthcare services and delays in routine eye examinations and treatments, the COVID-19 pandemic had a significant effect on the amblyopia treatment market. Lockdowns and other social distancing tactics decreased patient visits to ophthalmologists, which in many cases delayed the early detection and treatment of amblyopia. Additionally, some families deprioritized non-emergency healthcare, including treatment for amblyopia, due to financial strain and economic uncertainty brought on by the pandemic.

The Strabismic segment is expected to be the largest during the forecast period

The Strabismic Amblyopia segment has the largest market share in lazy eye (amblyopia). As a result of an eye misalignment known as strabismus, strabismic amblyopia is the most prevalent type of amblyopia. Poor visual development in the misaligned eye results from the brain favoring one eye over the other to prevent double vision. In order to align the eyes and improve vision, early diagnosis and treatment are essential. Furthermore, these procedures frequently involve the use of eye patches, corrective glasses, or surgery.

The Photo screening segment is expected to have the highest CAGR during the forecast period

The photo screening segment of the lazy eye (amblyopia) market is anticipated to grow at the highest CAGR. Photo screening is taking pictures of a child's eyes with specialized cameras and software. These images are then analyzed to find amblyopia risk factors like strabismus or refractive errors. Because it is quick, non-invasive, and simple to use on young children who might not cooperate for traditional eye exams, this method is especially beneficial. Moreover, this market is expanding quickly due to a number of factors, including increased adoption of pediatric screenings, photo screening technology advancements, and a growing understanding of the value of early detection.

Region with largest share:

Due to its sophisticated healthcare system, high awareness, and easy access to treatment options, North America-and especially the United States-dominate the market for lazy eyes. Because lazy eye cases are so common in the US, there is a healthy market there that is backed by strong pharmaceutical companies, esteemed research facilities, and a proactive approach to treating vision disorders. Additionally, the nation's notable market share in the North American lazy eye market can be attributed to its focus on healthcare innovation and the extensive accessibility of treatment modalities.

Region with highest CAGR:

The lazy eye market has the highest CAGR in the Asia-Pacific region, which includes nations like China, Japan, and India. Factors like rising healthcare costs, increased public awareness of eye conditions, and easier access to healthcare, especially in rural areas, are driving this growth. Furthermore, with their sizable populations, nations like China and India present substantial growth prospects because of the increased incidence of lazy eye cases and the increased attention being paid to the development of healthcare infrastructure.

Key players in the market

Some of the key players in Lazy Eye market include Johnson And Johnson Services, Inc, Golden Vision, Krafty Eye Patches, Adwia Pharmaceuticals, NovaSight, 3M, Pfizer Inc, TCI Chemicals Pvt. Ltd, Rebion, Bausch & Lomb Incorporated, Opthopatch, Vivid Vision, Inc, Hilco Vision, Walgreens and Fresnel Prism & Lens.

Key Developments:

In May 2024, Johnson & Johnson has entered into a definitive agreement to acquire Proteologix Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, for $850 million in cash, with potential for an additional milestone payment.

In January 2024, 3M Health Care announced that its Medical Solutions Division received a $34.2 million award from the U.S. Army Medical Research Acquisition Activity. The award enables 3M to develop a range of new solutions for infection prevention, wound management and wound healing.

In September 2023, Bausch + Lomb Corporation, a subsidiary of Bausch Health Companies Inc. announced it has completed its acquisition of XIIDRA(R) 5%, a non-steroid eye drop specifically approved to treat the signs and symptoms of dry eye disease focusing on inflammation associated with dry eye, and certain other ophthalmology assets.

Types Covered:

  • Strabismic
  • Refractive Amblyopia
  • Deprivation Amblyopia
  • Anisometropia Amblyopia
  • Reverse Amblyopia
  • Other Types

Diagnosis Covered:

  • Squint Test
  • General Eye Test
  • Visual Acuity Tests
  • Photo Screening
  • Bruckner Test

Treatments Covered:

  • Corrective Eyewear
  • Surgery
  • Eye Patches
  • Atropine Eye Drops
  • Video Game
  • Other Treatments

Applications Covered:

  • Hospitals
  • Specialty Clinics
  • Retail Pharmacies
  • Eye Care Clinics
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Lazy Eye Market, By Type

  • 5.1 Introduction
  • 5.2 Strabismic
  • 5.3 Refractive Amblyopia
  • 5.4 Deprivation Amblyopia
  • 5.5 Anisometropia Amblyopia
  • 5.6 Reverse Amblyopia
  • 5.7 Other Types

6 Global Lazy Eye Market, By Diagnosis

  • 6.1 Introduction
  • 6.2 Squint Test
  • 6.3 General Eye Test
  • 6.4 Visual Acuity Tests
  • 6.5 Photo Screening
  • 6.6 Bruckner Test

7 Global Lazy Eye Market, By Treatment

  • 7.1 Introduction
  • 7.2 Corrective Eyewear
    • 7.2.1 Contact Lenses
    • 7.2.2 Glasses
  • 7.3 Surgery
  • 7.4 Eye Patches
  • 7.5 Atropine Eye Drops
  • 7.6 Video Game
  • 7.7 Other Treatments

8 Global Lazy Eye Market, By Application

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Specialty Clinics
  • 8.4 Retail Pharmacies
  • 8.5 Eye Care Clinics
  • 8.6 Other Applications

9 Global Lazy Eye Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Johnson And Johnson Services, Inc
  • 11.2 Golden Vision
  • 11.3 Krafty Eye Patches
  • 11.4 Adwia Pharmaceuticals
  • 11.5 NovaSight
  • 11.6 3M
  • 11.7 Pfizer Inc
  • 11.8 TCI Chemicals Pvt. Ltd
  • 11.9 Rebion
  • 11.10 Bausch & Lomb Incorporated
  • 11.11 Opthopatch
  • 11.12 Vivid Vision, Inc
  • 11.13 Hilco Vision
  • 11.14 Walgreens
  • 11.15 Fresnel Prism & Lens

List of Tables

  • Table 1 Global Lazy Eye Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Lazy Eye Market Outlook, By Type (2022-2030) ($MN)
  • Table 3 Global Lazy Eye Market Outlook, By Strabismic (2022-2030) ($MN)
  • Table 4 Global Lazy Eye Market Outlook, By Refractive Amblyopia (2022-2030) ($MN)
  • Table 5 Global Lazy Eye Market Outlook, By Deprivation Amblyopia (2022-2030) ($MN)
  • Table 6 Global Lazy Eye Market Outlook, By Anisometropia Amblyopia (2022-2030) ($MN)
  • Table 7 Global Lazy Eye Market Outlook, By Reverse Amblyopia (2022-2030) ($MN)
  • Table 8 Global Lazy Eye Market Outlook, By Other Types (2022-2030) ($MN)
  • Table 9 Global Lazy Eye Market Outlook, By Diagnosis (2022-2030) ($MN)
  • Table 10 Global Lazy Eye Market Outlook, By Squint Test (2022-2030) ($MN)
  • Table 11 Global Lazy Eye Market Outlook, By General Eye Test (2022-2030) ($MN)
  • Table 12 Global Lazy Eye Market Outlook, By Visual Acuity Tests (2022-2030) ($MN)
  • Table 13 Global Lazy Eye Market Outlook, By Photo Screening (2022-2030) ($MN)
  • Table 14 Global Lazy Eye Market Outlook, By Bruckner Test (2022-2030) ($MN)
  • Table 15 Global Lazy Eye Market Outlook, By Treatment (2022-2030) ($MN)
  • Table 16 Global Lazy Eye Market Outlook, By Corrective Eyewear (2022-2030) ($MN)
  • Table 17 Global Lazy Eye Market Outlook, By Contact Lenses (2022-2030) ($MN)
  • Table 18 Global Lazy Eye Market Outlook, By Glasses (2022-2030) ($MN)
  • Table 19 Global Lazy Eye Market Outlook, By Surgery (2022-2030) ($MN)
  • Table 20 Global Lazy Eye Market Outlook, By Eye Patches (2022-2030) ($MN)
  • Table 21 Global Lazy Eye Market Outlook, By Atropine Eye Drops (2022-2030) ($MN)
  • Table 22 Global Lazy Eye Market Outlook, By Video Game (2022-2030) ($MN)
  • Table 23 Global Lazy Eye Market Outlook, By Other Treatments (2022-2030) ($MN)
  • Table 24 Global Lazy Eye Market Outlook, By Application (2022-2030) ($MN)
  • Table 25 Global Lazy Eye Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 26 Global Lazy Eye Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 27 Global Lazy Eye Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
  • Table 28 Global Lazy Eye Market Outlook, By Eye Care Clinics (2022-2030) ($MN)
  • Table 29 Global Lazy Eye Market Outlook, By Other Applications (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.